PMA device
EPi-Sense®, EPi-Sense ST Guided Coagulation System
AtriCure, Inc. · Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation (OCM, Class III) · First FDA decision Dec 27, 2022, newest Dec 27, 2022Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "EPi-Sense EPi-Sense ST"
MAUDE reports
0
Brand "EPi-Sense EPi-Sense ST", since 2015
PubMed studies
0
Mentioning "EPi-Sense EPi-Sense ST"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing EPi-Sense®, EPi-Sense ST Guided Coagulation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- EPi-Sense®, EPi-Sense ST Guided Coagulation SystemPMA supplement
P200002-S004 · Decided Dec 27, 2022 · 90 days after receipt · Normal 180 Day Track
Device type: Surgical cardiac ablation device, for treatment of atrial fibrillation (OCM) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Surgical Treatment of NailsProposed local determinationProposedDL40462Noridian Healthcare Solutions, LLCUpdated Sep 23, 2026
- Surgical Treatment of Obstructive Sleep Apnea (OSA)Local determinationIn effectL34526WPS Insurance CorporationUpdated Jun 16, 2025
- Surgical Treatment of NailsLocal determinationIn effectL33833First Coast Service Options, Inc.Updated Mar 14, 2025
- Surgical Treatment of NailsLocal determinationIn effectL34887Novitas Solutions, Inc.Updated Mar 14, 2025
- Surgical Treatment of NailsLocal determinationIn effectL39258Palmetto GBAUpdated Mar 3, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "EPi-Sense EPi-Sense ST", any status and sponsor, newest update first.
- CONVERGE Post-Approval Study (PAS)Active, not recruiting
AtriCure, Inc.Public (ATRC)
NCT05393180 · 53 participants · Start Apr 13, 2022 · Primary completion Feb 26, 2027
Device: Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF · For: Chronic Atrial Fibrillation
Sites: San Francisco, California; Hartford, Connecticut; Clearwater, Florida · 13 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EPi-Sense EPi-Sense ST", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OCM
70 reports: 10 malfunction, 53 injury, 7 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "EPi-Sense EPi-Sense ST"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OCM.
- AtriCure Synergy Ablation SystemAtriCure, Inc. · PMA 2022
- EPi-Sense Guided Coagulation SystemAtriCure, Inc. · PMA 2025
- Synergy Ablation SystemAtriCure, Inc. · PMA 2025
- Cannula with GuideAtriCure, Inc. · PMA 2024
- EPi-Sense® ST Guided Coagulation SystemAtriCure, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.